Accelerating Drug Discovery with AI and Next-Generation Automation The pharmaceutical industry is currently witnessi ...

Crown Bioscience is a global contract research organization (CRO) specializing in oncology drug discovery and development, today announced it has joined Critical Path Institute's (C-Path) New Approach ...

Recent advances in molecular pharmacology, systems biology, genomics, and transcriptomics have transformed our understanding of disease pathogenesis and ...

This article explores how advances in AI, structural biology, and new drug modalities are transforming “undruggable” proteins ...

Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...

Large language models (LLMs) can be broadly applied across multiple key stages in drug development: (1) Target identification and drug screening. Llama-Gram, GPCR LLM, and ProtChat systems effectively ...

Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.

The partnership will connect Evogene’s AI-based ChemPass AI with the BCDD’s laboratory infrastructure.

Researchers have screened thousands of approved drugs against a network of 2,358 longevity-linked genes, producing a ...

On June 22, SK Biopharmaceuticals announced at the 2026 BIO International Convention in the United States that it had signed a research and developmen ...